Menu
Back to Journals » Drug Design, Development and Therapy » Volume 12
Original Research
Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathway
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,542 | Dovepress* | 9,151+ | 742 | 9,893 | |
| PubMed Central* | 391 | 137 | 528 | ||
| Totals | 9,542 | 879 | 10,421 | ||
| *Since 22 November 2018 | |||||
View citations on PubMed Central and Google Scholar